Others

Items 7951-8000 of 13502

Page
per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Citations
  1. Drug Intermediate

    2-Amino-4-methoxyphenol is a valuable drug intermediate primarily utilized in the synthesis of pyridine analogues. This compound has potential applications in medicinal chemistry and can serve as a precursor in the development of biologically active molecules. Its unique structural features contribute to its versatility in research and development within pharmaceutical applications.
  2. Drug Intermediate

    (R)-5,6,7,8-Tetrahydroquinolin-8-amine hydrochloride serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound facilitates the development of therapeutic agents, particularly in the field of medicinal chemistry, contributing to the creation of novel drug candidates for various diseases. Its unique chemical structure positions it as an essential building block in drug discovery and development processes.
  3. Drug Intermediate

    (R)-2-Phenylmorpholine is a versatile compound utilized as a drug intermediate in organic synthesis. It plays a crucial role in the development of STAT5/6 PROTAC degraders and inhibitors, making it valuable in targeted protein degradation research. Its structural features contribute to the design of novel therapeutic agents, facilitating advancements in biomedical research.
  4. Drug Intermediate

    3,5-Dichloropyridine-4-acetic acid serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This reagent is instrumental in various organic chemistry applications, contributing to the development of therapeutic agents. Its unique structure allows for modifications that facilitate the creation of targeted drug molecules.
  5. Drug Intermediate

    4-Fluorobenzoic acid serves as a key drug intermediate in the synthesis of hydrazone derivatives, known for their antituberculosis activity. Additionally, it is involved in creating Schiff bases that exhibit DPPH radical scavenging properties, making it valuable for research in medicinal chemistry and antioxidant studies. Its unique chemical structure facilitates diverse applications in the development of pharmacologically relevant compounds.
  6. Drug Impurity

    Rametimide impurity 16 is a structural impurity associated with Rametimide. This compound is critical for assessing the purity and quality of Rametimide formulations in pharmaceutical development. It serves as an important reference standard in drug analysis, stability testing, and regulatory compliance, aiding researchers in ensuring the integrity of their chemical formulations.
  7. Drug Intermediate

    4-Fluoro-5-hydroxy-2-methylindole serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This chemical enhances the production of indole derivatives that are significant in pharmaceutical research. Researchers can utilize this compound in the development of novel therapeutics and in the exploration of indole-based biological activities.
  8. Drug Intermediate

    4-Chloro-3-(4-ethoxybenzyl)phenol acts as a versatile drug intermediate in the synthesis of various active pharmaceutical ingredients. This compound exhibits critical chemical properties that facilitate the development of biologically active molecules, making it essential for research in medicinal chemistry. Its utility in creating complex structures underscores its significance in drug discovery and development processes.
  9. Drug Intermediate

    3-Methyl-4-(pyridin-4-yl)aniline is a chemical intermediate commonly used in the synthesis of various active pharmaceutical compounds. This compound features a pyridinyl moiety that can enhance biological activity, making it valuable in drug development and medicinal chemistry research. Its versatility in organic synthesis supports investigations into the design and optimization of therapeutic agents.
  10. Drug Intermediate

    (2R,5S)-1-tert-Butyl 2-ethyl 5-aminopiperidine-1,2-dicarboxylate serves as a vital drug intermediate in pharmaceutical chemistry. This compound is instrumental in the synthesis of a variety of biologically active molecules, facilitating the development of novel therapeutics. Its structural features enable efficient transformations and contribute to the assembly of complex drug scaffolds, making it a valuable reagent for drug discovery and development efforts.
  11. Drug Intermediate

    1-(Benzyloxy)-2-iodobenzene is primarily utilized as a drug intermediate in the synthesis of diverse active pharmaceutical compounds. Its unique structure allows for modifications that can enhance biological activity and optimize pharmacological properties. This compound is valuable in medicinal chemistry research, facilitating the development of new therapeutic agents.
  12. Drug Intermediate

    3,5-Diethylisoxazole-4-carboxylic acid serves as a versatile drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound facilitates the development of novel therapeutic agents by providing a structural framework for further modifications. Its utility in organic synthesis makes it an essential reagent for researchers focused on pharmaceutical development and chemical biology studies.
  13. Drug Intermediate

    Methyl 3-((tert-butoxycarbonyl)amino)-5-iodothiophene-2-carboxylate serves as a drug intermediate, playing a crucial role in the synthesis of diverse bioactive compounds. Its structure facilitates the incorporation of iodine and amino groups, making it valuable in pharmaceutical research and development. This reagent is suited for use in the creation of compounds with potential therapeutic applications.
  14. Drug Intermediate

    Methyl N-boc-3-chloro-L-alaninate serves as a valuable drug intermediate in the synthetic pathway of diverse active pharmaceutical ingredients. This compound is instrumental in facilitating the development of bioactive molecules, particularly in medicinal chemistry research. Its reactivity and functional groups make it a suitable candidate for further modifications in the synthesis of complex organic structures.
  15. Drug Impurity

    Fluralaner impurity 2 is a drug impurity associated with the insecticide Fluralaner, which primarily targets the GABA and glutamate-gated chloride channels in arthropods. This compound serves as a valuable reference standard for analytical applications in quality control and method development related to Fluralaner synthesis and formulation. Its characterization aids in understanding the impurities' impact on pharmacological efficacy and safety profiles in research and regulatory contexts.
  16. Drug Intermediate

    4-Hydroxy-3-methoxy-5-nitrobenzoic acid serves as a crucial drug intermediate in the synthesis of various pharmaceutical compounds. Its unique chemical structure enables effective modifications, facilitating the development of bioactive molecules. This reagent is frequently utilized in medicinal chemistry research aimed at the design and optimization of therapeutic agents.
  17. Drug Intermediate

    (2R,3S)-2-(4-(Cyclopentylamino)phenyl)-1-(2-fluoro-6-methylbenzoyl)piperidine-3-carboxylic acid serves as a crucial drug intermediate in the synthesis of various bioactive compounds. Its distinct structural features facilitate the development of pharmaceuticals targeting a range of biological pathways. This compound is essential for researchers focusing on medicinal chemistry and drug discovery, advancing the development of new therapeutic agents.
  18. Drug Intermediate

    4,5,6,7-Tetrahydrobenzo[d]isoxazol-5-amine hydrochloride serves as a key drug intermediate in the synthesis of diverse pharmacological compounds. This versatile reagent is utilized extensively in medicinal chemistry to facilitate the development of novel therapeutic agents. Its structural characteristics enable the modification and enhancement of biological activity in target compounds, making it valuable for drug discovery and development efforts.
  19. Drug Intermediate

    1-(4-Chloro-2-hydroxyphenyl)ethan-1-one serves as a critical drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound is utilized in the development of various therapeutic agents, facilitating the creation of innovative treatments through its reactive functional group. Researchers employ it in medicinal chemistry to streamline the synthesis of bioactive molecules.
  20. Drug Intermediate

    3,5-Dihydroxyadamantan-1-yl methacrylate is a versatile drug intermediate primarily used in the synthesis of various bioactive compounds. This reagent facilitates the incorporation of adamantane-derived structures, which may enhance the pharmacological profile of synthesized drugs. Its utility in medicinal chemistry positions it as a valuable tool for researchers focusing on drug development and modification.
  21. Drug Intermediate

    1,4-Cyclohexanedione serves as a crucial drug intermediate due to its role as a substrate for the EryKR1 domain. This compound exhibits unique biocatalytic activity and stereospecificity, making it valuable for various synthetic applications in pharmaceutical research. Its ability to participate in stereochemical transformations further supports its utility in the development of complex organic molecules.
  22. Drug Intermediate

    5-Ethoxypyrrolidin-2-one is a versatile drug intermediate that plays a critical role in the synthesis of various active compounds. Its key structural features facilitate the development of pharmacologically relevant entities in medicinal chemistry. This reagent is employed in the preparation of novel pharmaceuticals, aiding researchers in exploring diverse therapeutic avenues.
  23. Drug Intermediate

    (E)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one is a chemical intermediate primarily utilized in the synthesis of various bioactive compounds. Its structural characteristics support the development of pharmaceuticals, enabling the formation of diverse thiazolidinone derivatives. This compound serves as a valuable building block in medicinal chemistry and contributes to drug discovery efforts through the exploration of novel therapeutic agents.
  24. Drug Intermediate

    3-Cyanobicyclo[1.1.1]pentane-1-carboxylic acid serves as a critical intermediate in the synthesis of various bioactive compounds. This compound is utilized in pharmaceutical research to facilitate the development of novel therapeutics. Its unique bicyclic structure makes it a valuable building block in organic synthesis, enabling the creation of complex molecules with potential medicinal properties.
  25. Drug Impurity

    Paliperidone impurity 3 is a known impurity of the antipsychotic agent Paliperidone, which primarily targets dopamine receptors. This compound is utilized in pharmaceutical research for quality control and to assess the purity of Paliperidone formulations. It serves as a crucial reference standard in the development and validation of analytical methods, ensuring compliance with regulatory standards in drug production.
  26. Drug Intermediate

    tert-Butyl (2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)carbamate serves as a versatile drug intermediate, facilitating the synthesis of a range of active pharmaceutical compounds. This reagent is valuable for researchers engaged in the development of novel therapeutics, enabling the exploration of complex molecular structures and their bioactive potential. Its unique chemical properties make it an essential tool in medicinal chemistry.
  27. Drug Intermediate

    N-(Chloroacetyl)-2-methoxybenzamide is a synthetic intermediate commonly utilized in the preparation of various pharmacologically active compounds. This reagent facilitates chemical reactions critical for drug development, particularly in the synthesis of amide derivatives. Its versatility makes it an essential tool in medicinal chemistry and related research applications.
  28. Drug Intermediate

    1H-Pyrazole-1-carboxylic acid, 3-amino-5-cyclobutyl-, 1,1-dimethylethyl ester serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. This compound is particularly relevant in the development of PROTACs targeting CDK9, facilitating studies of protein degradation pathways in cancer research. Its unique structural features make it a valuable reagent in medicinal chemistry and drug discovery applications.
  29. Drug Intermediate

    1-Boc-4-(4-aminobutyl)piperazine is a versatile drug intermediate that serves as a building block in the synthesis of various bioactive compounds. This piperazine derivative is useful for facilitating the development of pharmaceuticals with potential therapeutic applications. Its functional groups allow for modifications that can enhance bioactivity and selectivity, making it a valuable reagent in medicinal chemistry research.
  30. Drug Intermediate

    Ethyl 3-(2,6-dichloropyridin-3-yl)-3-oxopropanoate serves as a versatile drug intermediate in the synthesis of various pharmacologically active compounds. This compound facilitates the construction of useful molecular frameworks for chemical research, contributing to the development of novel therapeutic agents. Its unique structure allows for diverse applications in medicinal chemistry and drug discovery efforts.
  31. Drug Intermediate

    5-Benzyl-2,2-dimethyl-1,3-dioxane-4,6-dione serves as a crucial drug intermediate in the synthesis of various bioactive compounds. This compound facilitates the production of pharmaceutical agents through condensation reactions, enabling the development of new therapeutics. Its unique chemical structure supports diverse applications in medicinal chemistry research.
  32. Drug Intermediate

    tert-Butyl 4-amino-3-fluorobenzoate is a versatile drug intermediate utilized in the synthesis of various active pharmaceutical compounds. Its fluorinated aromatic structure enhances reactivity, making it an important building block in medicinal chemistry. This reagent is particularly valuable for researchers aiming to develop novel therapeutic agents with improved pharmacological properties.
  33. Drug Intermediate

    4,6-Dichloro-2-(propylthio)pyrimidin-5-amine acts as a drug intermediate, primarily utilized in the synthesis of a variety of active pharmaceutical compounds. Its unique chemical structure and reactivity make it valuable in medicinal chemistry for developing novel therapeutics. This compound is essential for researchers looking to create targeted drug molecules with specific biological activities.
  34. Drug Intermediate

    (S)-1-((S)-2-(3,4,5-Trimethoxyphenyl)butanoyl)piperidine-2-carboxylic acid serves as a crucial drug intermediate in the synthesis of various bioactive compounds. It is instrumental in the development of novel pharmaceuticals, particularly in the study of piperidine derivatives for therapeutic applications. This compound facilitates the exploration of structure-activity relationships to enhance drug efficacy and specificity in medicinal chemistry research.
  35. Drug Intermediate

    5-Bromo-3-iodo-4-azaindole serves as a versatile drug intermediate facilitating the synthesis of various bioactive compounds. This halogenated azaindole derivative is essential in the development of pharmaceuticals, with potential applications in medicinal chemistry and organic synthesis. Its unique structure offers opportunities for the modification and optimization of biologically relevant molecules.
  36. Drug Intermediate

    α-Pyrone serves as a versatile drug intermediate with important implications in pharmaceutical synthesis. Its derivatives exhibit notable cytotoxic properties, making it valuable for the development of anticancer agents. This compound is particularly relevant in the study of chemical mechanisms and therapeutic applications in drug discovery and development.
  37. Drug Impurity

    2-Methoxy-5-formylbenzoic acid is characterized as a drug impurity. It may arise during the synthesis of pharmaceutical compounds and is relevant for quality control in drug development. Its presence can affect the safety and efficacy profiles of drug products, making it crucial for researchers to monitor and analyze in various chemical analyses.
  38. Drug Intermediate

    8-(Trifluoroacetyl)-7,8,9,10-tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline serves as a critical drug intermediate in the synthesis of various biologically active compounds. Its structural characteristics facilitate diverse chemical transformations, making it valuable for pharmaceutical research and development. This compound enables the exploration of novel therapeutic agents across multiple disease areas.
  39. Drug Intermediate

    1,7-Naphthyridin-3-amine serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its unique structure facilitates the development of various pharmaceutical agents, making it an important building block in medicinal chemistry. This compound is employed extensively in research applications focused on drug development and optimization.
  40. Drug Intermediate

    5-(1-Methylcyclopropoxy)-1H-indazole serves as a versatile drug intermediate, facilitating the synthesis of diverse active pharmaceutical ingredients. This compound is significant in medicinal chemistry for its potential in the development of novel therapeutics. Its unique structural features may aid in enhancing biological activity and optimizing drug properties in research applications.
  41. Drug Intermediate

    (E)-4,4,4-Trifluorobut-2-en-1-ol serves as an important drug intermediate in the synthesis of various pharmaceutical compounds. This compound is characterized by its unique electrophilic properties, facilitating chemical transformations in the development of bioactive agents. Its utility spans multiple research applications, contributing to the advancement of drug discovery and development efforts.
  42. Drug Intermediate

    (R)-1-(Naphthalen-1-yl)ethanamine hydrochloride serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. This compound facilitates the development of pharmaceuticals by providing a versatile building block for various organic transformations. Its structural attributes make it valuable in medicinal chemistry and drug discovery applications.
  43. Drug Intermediate

    N-((2S)-2-Amino-2-phenylethyl)-N,N-dimethylamine is a versatile drug intermediate utilized in the synthesis of diverse active pharmaceutical ingredients. This compound serves as an important building block for the development of various bioactive molecules with potential therapeutic applications. Its role in chemical synthesis supports research in medicinal chemistry and drug design, enabling the exploration of new pharmaceutical candidates.
  44. Drug Intermediate

    2-Aminomethylpyrimidine hydrochloride is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a key building block in the development of various drug candidates, facilitating the formation of complex molecular structures. Its relevance in medicinal chemistry makes it a valuable tool for researchers engaged in the synthesis of pyrimidine-based derivatives and other bioactive compounds.
  45. Drug Intermediate

    tert-Butyl (S)-2-vinylpyrrolidine-1-carboxylate serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the formation of various architecturally complex scaffolds, contributing to the development of bioactive molecules. Its utility in medicinal chemistry underscores its importance in the pharmaceutical research landscape.
  46. Drug Intermediate

    (E)-1,3-Di(thiophen-2-yl)prop-2-en-1-one serves as a versatile drug intermediate, facilitating the synthesis of a range of biologically active compounds. This compound is utilized in medicinal chemistry for the development of novel pharmaceuticals, particularly those targeting diverse therapeutic areas. Its unique structure enhances its applicability in constructing complex organic molecules.
  47. Drug Intermediate

    trans-2,5-Diethylpiperazine is a versatile drug intermediate primarily utilized in the synthesis of diverse active pharmaceutical compounds. Its unique structure facilitates the development of various nitrogen-containing molecules, making it an essential reagent in medicinal chemistry. Researchers can leverage its properties to explore new therapeutic agents and enhance drug discovery processes.
  48. Drug Impurity

    Paracetamol Impurity 1 is a known impurity of the analgesic compound Paracetamol. This chemical is significant for quality control and regulatory compliance in pharmaceutical formulations containing Paracetamol. Its presence may affect drug efficacy and patient safety, making it essential for researchers to analyze and quantify during the development and testing of Paracetamol-based medications.
  49. Drug Impurity

    Naproxen impurity 5 is a structural variant of Naproxen, primarily relevant in the context of drug formulation and stability studies. As a drug impurity, it serves as an important reference standard in analytical chemistry, allowing for the assessment of purity levels and potential effects on pharmacokinetics and toxicity profiles. Researchers can utilize this reagent for quality control, ensuring the safety and efficacy of Naproxen-containing pharmaceuticals.
  50. Drug Intermediate

    4-Fluoro-5-isopropyl-2-methoxyphenylboronic acid functions as a crucial drug intermediate in organic synthesis. It serves as a building block for the production of various biologically active compounds, facilitating research in medicinal chemistry and pharmaceuticals. Its unique structural properties enable the development of novel therapeutic agents for diverse applications.

Items 7951-8000 of 13502

Page
per page
Set Descending Direction